Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 118, Issue 4, 2002, Pages 1011-1018

  Carlotti, Emanuela ^a   Pettenella, Francesca ^b   Amaru, Ricardo ^a   Slater, Sarah ^c   Lister, T Andrew ^c   Barbui, Tiziano ^a   Basso, Giuseppe ^d   Cazzaniga, Giovanni ^b   Rambaldi, Alessandro ^a,e   Biondi, Andrea ^b  

^a Ospedali Riuniti Bergamo   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF PADOVA   (Italy)

^e OSPEDALI RIUNITI   (Italy)

Author keywords

Breakpoint; PCR; SIL; T ALL; TAL 1

Indexed keywords

COMPLEMENTARY DNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME 1P; CHROMOSOME ANALYSIS; CHROMOSOME MAP; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DNA DETERMINATION; DNA LIBRARY; EXON; FUSION GENE; GENBANK; GENE; GENE DELETION; GENE LOCUS; GENE MAPPING; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFANT; INTRON; MAJOR CLINICAL STUDY; MOLECULAR BIOLOGY; MOLECULAR CLONING; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SIL TAL 1 GENE; T LYMPHOCYTE;

ADOLESCENT; ADULT; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, SOUTHERN; CHILD; CHILD, PRESCHOOL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; DNA-BINDING PROTEINS; GENE DELETION; GENE REARRANGEMENT; HUMANS; INFANT; LEUKEMIA, T-CELL, ACUTE; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION; PROTEINS; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS;

EID: 18544386360     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03747.x     Document Type: Article

References (51)

1. Two pairs of recombination signals are sufficient to cause immunoglobulin V-(D)-J joining
2. The SCL gene is formed from a transcriptionally complex locus
3. Disruption of the human SCL locus by 'illegitimate' V-(D)-J recombinase activity
4. Structural characterisation of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukaemia
5. Disruption of the SCL gene by a t(1;3) translocation in a patient with T cell acute lymphoblastic leukaemia
6. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukaemia
7. Cloning and characterisation of TCTA, a gene located at the site of a t(1;3) translocation
8. TAL1, TAL2 and LYL1: A family of basic helix-loop-helix proteins implicated in T cell acute leukaemia
9. Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: A Paediatric Oncology Group study
10. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukaemia? A paediatric oncology group study
11. Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript
12. Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukaemias disrupt the 5′ part of the TAL-1 gene
13. A third TAL-1 promoter is specifically used in human T cell leukaemias
14. Molecular emergence of acute myeloid leukaemia during treatment for acute lymphoblastic leukaemia
15. Lineage-restricted regulation of the murine SCL/TAL-1 promoter
16. Site-specific deletions involving the TAL-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes
17. TAL-1 deletions in T-cell acute lymphoblastic leukaemia as PCR target for detection of minimal residual disease
18. Site-specific recombination of the TAL-1 gene is a common occurrence in human T cell leukemia
19. The TAL gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein
20. Coding sequences of the TAL-1 gene are disrupted by chromosome translocation in human T cell leukemia
21. SCL/TAL-1 expression in T-acute lymphoblastic leukemia: An immunohistochemical and genotypic study
22. Cloning and characterization of a murine SIL gene
23. Simultaneous SIL-TAL1 RT-PCR detection of all TAL(d) deletions and identification of novel TAL(d) variants
24. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia
25. SCL, the gene implicated in human T-cell leukaemia, is oncogenic in a murine T-lymphocyte cell line
26. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma
27. c-TAL, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-beta chain gene by a reciprocal chromosomal translocation: t(1;7)(p32;q35)
28. Deregulated expression of the TAL1 gene by t(1;5)(p32;31) in patient with T-cell acute lymphoblastic leukemia
29. Analysis of vertebrate SCL loci identifies conserved enhancers
30. Long-range comparison of human and mouse SCL loci: Localized regions of sensitivity to restriction endonucleases correspond precisely with peaks of conserved noncoding sequences
31. Erythroid expression of the 'helix-loop-helix' gene, SCL
32. SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain
33. V(D)J recombination: A functional definition of the joining signals
34. Expression of the TAL1 proto-oncogene in cultured endothelial cells and blood vessels of the spleen
35. Expression of the SIL gene is correlated with growth induction and cellular proliferation
36. The SIL gene is required for mouse embryonic axial development and left-right specification
37. Rearrangements of the TAL-1 locus as clonal markers for T cell acute lymphoblastic leukemia
38. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis
39. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the TAL-1 gene
40. Distinct DNase-I hypersensitive sites are associated with TAL-1 transcription in erythroid and T-cell lines
41. Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor alpha beta lineage
42. Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints
43. The T cell leukemia oncoprotein SCL/TAL-1 is essential for development of all hematopoietic lineages
44. The helix-loop-helix gene SCL: Implicated in T-cell acute lymphoblastic leukaemia and in normal haematopoietic development
45. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene
46. An SCL 3′ enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors
47. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein TAL-1/SCL
48. Distinct 5′-SCL enhancers direct transcription to developing brain, spinal cord, and endothelium: Neural expression is mediated by GATA factor binding sites
49. Helix-loop-helix genes translocated in lymphoid leukemia
50. Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system